A phase I study of vistusertib (dual mTORC1/2 inhibitor) in patients with previously treated glioblastoma multiforme: a CCTG study - Concepedia

Concepedia

Publication | Closed Access

A phase I study of vistusertib (dual mTORC1/2 inhibitor) in patients with previously treated glioblastoma multiforme: a CCTG study

35

Citations

33

References

2019

Year

Sarah Lapointe, Warren Mason, Mary MacNeil, Craig Harlos, Roger Y. Tsang, Joana Sederias, H. Artee Luchman, Samuel Weiss, John P. Rossiter, Dongsheng Tu,

Investigational New Drugs

Glioblastoma MultiformeDual Mtorc1/2 InhibitorMedicinePharmacologyPharmacotherapyNeurologyHigh-grade GliomasCancer TreatmentAnti-cancer AgentOncologyGliomaCctg Study

References

	Year	Citations

Page 1

Page 1